Stock LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Lixte Biotechnology Holdings, Inc.

Equities

LIXT

US5393193017

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-07-16 pm EDT 		5-day change 1st Jan Change
2.37 USD -1.66% Intraday chart for Lixte Biotechnology Holdings, Inc. +5.33% +0.85%
Jun. 14 Lixte Biotechnology Holdings, Inc. to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial CI
Jun. 06 Lixte Biotechnology Holdings, Inc. Reports Findings Show LIXTE's Lead Clinical Compound, LB-100, Increases Recognition of Colon Cancer Cells by the Immune System CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Other Biotechnology & Medical Research
-1.66%+5.33%+0.85%-56.35%-94.80% 5.33M
Neutral
Neutral
Neutral
  1. Stock Market
  2. Equities
  3. LIXT Stock
  4. Charts Lixte Biotechnology Holdings, Inc.
  5. Relative Strength Chart